Is CELC anticipated to rise today?

**Celcuity (CELC) is anticipated to rise today.** Here's why:

1. **Current Price Trend**: CELC's current price trend is bullish, with the stock price positioned above the wide resistance level. This indicates a strong upward momentum.
2. **Support and Resistance Levels**: The stock is currently above the narrow support level and the wide resistance level, which suggests that the price is likely to move towards the resistance level. Since the resistance level is significantly above the current price, there is potential for the stock to rise.
3. **Forecast Price Trend**: The forecast price trend for CELC is bullish, with a 53.16% historical win rate for this type of forecast. This indicates that the stock is likely to continue its upward trajectory.
4. **Analyst Ratings and Price Target**: The analyst rating for CELC is positive, with a price target raised to $50 from $27, which represents a significant upside potential. This suggests that analysts are optimistic about the stock's future performance.
5. **Recent News and Developments**: Celcuity has announced positive results from its Phase 3 clinical trial for its breast cancer drug, gedatolisib, which has led to a significant surge in the stock price. The momentum from these positive results is likely to continue, driving the stock higher.

In conclusion, based on the current price trend, support and resistance levels, forecast price trend, analyst ratings, and recent developments, CELC is anticipated to rise today. Investors may consider buying the stock, keeping in mind the potential for significant gains. However, it's important to note that investing involves risks, and investors should conduct thorough due diligence before making investment decisions.